Drug
Fdc
Fdc: highest development phase Phase 3, developed by Ferrer, Intercept Pharmaceuticals. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Ferrer, Intercept Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| FDC NCT01321255 | Phase 3 | Myocardial Infarction |
| FDC tablet (OCA 5 mg + BZF 400 mg SR) NCT06488911 | Phase 3 | Primary Biliary Cholangitis |
Latest
No recent events.
Follow Fdc on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.